Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Validating a Digital Mobility Assessment in Parkinson's Disease Using Wearable Technology - the Mobilise-D Extension Study.
Authors not listed
Newcastle-upon-Tyne Hospitals NHS Trust · 2023
Abstract
The goal of this observational study is to investigate the ability of a mobility monitor to measure and predict outcomes in Parkinson's disease (PD). It is an extension of a previous study (the Mobilise-D Clinical Validation Study) and consists of an additional follow-up visit for PD participants and the recruitment of age matched control participants. The data will inform researchers about PD disease progression and normal changes in mobility associated with aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Anonymous. (2023). Validating a Digital Mobility Assessment in Parkinson's Disease Using Wearable Technology - the Mobilise-D Extension Study. <em>Newcastle-upon-Tyne Hospitals NHS Trust</em>. https://clinicaltrials.gov/study/NCT05874739
Vancouver
Anonymous. Validating a Digital Mobility Assessment in Parkinson's Disease Using Wearable Technology - the Mobilise-D Extension Study. Newcastle-upon-Tyne Hospitals NHS Trust. 2023.
BibTeX
@misc{anon2023Valida,
title = {Validating a Digital Mobility Assessment in Parkinson's Disease Using Wearable Technology - the Mobilise-D Extension Study.},
author = {Anonymous},
journal = {Newcastle-upon-Tyne Hospitals NHS Trust},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Parkinsonism & Related Disorders 2022
Citation only
Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study
Experimental Neurology 2017
Preprint · CC-BY
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
ERJ Open Research 2023
Open access · CC-BY
Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study
Merck Sharp & Dohme LLC 2008
Open access · US-GOV